Trials Sponsors Conditions Drugs Pricing

Conditions

Genetic Predisposition to Cancer

Outcome Measures

Primary Outcomes (1)

Register and follow up over time individuals assessed for suspected genetic predisposition to cancer
Register and follow up over time individuals assessed for suspected genetic predisposition to cancer
15 years

Secondary Outcomes (1)

Possibility of conducting studies targeted at specific objectives
15 years

Study Arms (2)

Prospective

During oncology genetic counselling, together with the standard forms usually applied, the information sheet concerning participation in the register will also be sent to users who meet the inclusion criteria.

Retrospective

For patients who underwent oncological genetic counselling before the start of the registry, retrospective recruitment will be carried out by means of re-contact for the purpose of proposing joining the registry.

Eligibility Criteria

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

All users attending Oncology Genetics outpatient clinics will be registered. The user population of these outpatient clinics includes all patients assessed for hereditary cancer risk regardless of age, gender, disease status and genetic testing. The register will include both the proband, i.e. the first person in the family to undergo an oncological genetic assessment, and any family members who perform the assessment subsequently.

You may qualify if:

participants aged 0 days or older at the time of genetic counselling

Sponsors & Collaborators

IRCCS Azienda Ospedaliero-Universitaria di Bologna
Otherlead

Study Sites (1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola

Bologna, Italy, 40138, Italy

Study Officials

Daniela Turchetti, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola
PRINCIPAL INVESTIGATOR

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Target Duration: 15 Years
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

November 28, 2024

First Posted

January 30, 2025

Study Start

May 1, 2022

Actual (reported)

Primary Completion

December 31, 2037

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Single-institution Register of Individuals Undergoing Cancer Genetic Risk Assessment

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Prospective

Retrospective

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Prospective

Retrospective

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations